Your browser doesn't support javascript.
loading
Tibial nerve stimulation in the management of primary sexual dysfunction in patients with multiple sclerosis: a pilot randomized control trial.
Giannopapas, Vasileios; Smyrni, Vassiliki; Kitsos, Dimitrios K; Chasiotis, Athanasios K; Stavrogianni, Konstantina; Papagiannopoulou, Georgia; Tsivgoulis, Georgios; Voumvourakis, Konstantinos; Giannopoulos, Sotirios; Bakalidou, Daphne.
Afiliação
  • Giannopapas V; Second Department of Neurology, University of Athens, Athens, Greece.
  • Smyrni V; Department of Physical Therapy, University of West Attica, Athens, Greece.
  • Kitsos DK; Laboratory of Neuromuscular and Cardiovascular Study of Motion, University of West Attica, Athens, Greece.
  • Chasiotis AK; Second Department of Neurology, University of Athens, Athens, Greece.
  • Stavrogianni K; Second Department of Neurology, University of Athens, Athens, Greece.
  • Papagiannopoulou G; Second Department of Neurology, University of Athens, Athens, Greece.
  • Tsivgoulis G; Department of Physical Therapy, University of West Attica, Athens, Greece.
  • Voumvourakis K; Laboratory of Neuromuscular and Cardiovascular Study of Motion, University of West Attica, Athens, Greece.
  • Giannopoulos S; Second Department of Neurology, University of Athens, Athens, Greece.
  • Bakalidou D; Department of Physiology, Faculty of Medicine, University of Ioannina, Ioannina, Greece.
Neurol Sci ; 2024 Jul 16.
Article em En | MEDLINE | ID: mdl-39009893
ABSTRACT

INTRODUCTION:

Sexual dysfunction (SD) is a common symptom that affects 40-90% of patients with multiple sclerosis (MS). Previous studies have highlighted the negative impact of sexual dysfunction in the mental health status and overall quality of life in patients with MS.

METHODS:

The aim of this study was to examine the effects of transcutaneous tibial nerve stimulation (TTNS) in the primary SD symptoms in patients with MS. A total of 40 participants were randomized (11 ratio) to either TTNS or Sham group and received three 20 min sessions over the course of two months. Pre and post intervention SD was evaluated using the Multiple Sclerosis Intimacy Questionnaire (MISQ-15).

RESULTS:

Statistically significant improvements in the aspects of primary sexual dysfunction were observed in the TTNS group pre-post intervention (specifically erectile function (for males)/vaginal lubrication (for females) (p < .001), orgasm quality and satisfaction for both male and female patients (p < .001), sexual desire (p < .05) and bladder related symptomatology (p < .005). In the sham group pre-post intervention, the only observed improvement was in the sexual desire aspect (p < .05). Post intervention the groups significantly differed erectile function/vaginal lubrication and orgasm quality and satisfaction (p < .05).

CONCLUSIONS:

Our findings underline the efficacy of TTNS in improving primary SD symptoms as well as bladder problems in both male and female patients with MS. TTNS demonstrated significant improvement in the following domains erectile function, vaginal lubrication, orgasm quality, satisfaction, bladder-related symptoms, and sexual desire.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article